In patients with low expression on the other hand, the most strongly regulated protein was SLC16A4, which has been recently described to be involved in alterations of glucose and lactate metabolism and metastasis also in NSCLC [41–43]. Here, SLC16A4 is linked to non-small cell lung carcinoma.